These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19089966)

  • 1. Step-by-step StentBoost-guided small vessel stenting using the self-expandable Sparrow stent-in-wire.
    Agostoni P; Verheye S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):78-83. PubMed ID: 19089966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel self-expanding stent system for enhanced provisional bifurcation stenting: Examination by StentBoost and intravascular ultrasound.
    Agostoni P; Verheye S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):481-7. PubMed ID: 19133672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifurcation stenting with a dedicated biolimus-eluting stent: X-ray visual enhancement of the final angiographic result with "StentBoost Subtract".
    Agostoni P; Verheye S
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):233-6. PubMed ID: 17377996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
    Utunomiya M; Katoh O; Nakamura S
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating the left main bifurcation lesion: the "three stent solution".
    Uretsky BF
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):42-3. PubMed ID: 19089935
    [No Abstract]   [Full Text] [Related]  

  • 8. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.
    Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es GA; Buszman P; Linke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S
    JACC Cardiovasc Interv; 2009 Sep; 2(9):861-70. PubMed ID: 19778775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bare metal stent with pioglitazone versus sirolimus-eluting stent for percutaneous coronary intervention in patients with Type 2 diabetes mellitus.
    Nishio K; Shigemitsu M; Kodama Y; Konno N; Katagiri T; Kobayashi Y
    Cardiovasc Revasc Med; 2009; 10(1):5-11. PubMed ID: 19159848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete fracture and migration of a coronary sirolimus-eluting stent.
    Eshtehardi P; Ghassemi-Kakroodi P; Mousavi N; Garachemani A; Moayed DA
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):271-3. PubMed ID: 20671570
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation.
    Ovünç K; Yorgun H; Ozer N
    Cardiovasc Revasc Med; 2009; 10(4):252-4. PubMed ID: 19815173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal stent expansion and complete neointimal coverage: does this association make sense?
    Mintz GS; Choi SY
    JACC Cardiovasc Interv; 2009 Oct; 2(10):995-6. PubMed ID: 19850261
    [No Abstract]   [Full Text] [Related]  

  • 17. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization.
    Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Saia F; Taglieri N; Aquilina M; Baldazzi F; Silenzi S; Cooke RM; Reggiani ML; Branzi A
    Catheter Cardiovasc Interv; 2007 May; 69(6):790-8. PubMed ID: 17290437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study.
    Webster M; Harding S; McClean D; Jaffe W; Ormiston J; Aitken A; Watson T
    EuroIntervention; 2013 May; 9(1):46-53. PubMed ID: 23685294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficult stent delivery: use of an aspiration catheter as a "sheath".
    Ashikaga T; Nishizaki M; Yamawake N
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):909-12. PubMed ID: 18383152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.